I wanted to make sure everyone saw this news from the Administration about new tools and efforts to close the gap in Part D Extra Help/LIS enrollment:
https://www.hhs.gov/about/news/2023/06/12/fact-sheet-biden-harris-administration-announces-new-tools-lower-prescription-drug-costs-low-income-seniors-people-disabilities.html
In particular, I wanted to share this new data file that CMS has released, which provides a breakdown of LIS enrollment by different demographic characteristics.
Brandy
From: ACL Updates <xxxxxx@connect.hhs.gov>
Sent: Tuesday, June 13, 2023 2:31 PM
To: Brandy Bauer <xxxxxx@ncoa.org>
Subject: Biden-Harris Administration Announces New Tools to Lower Prescription Drug Costs
Caution. This email is EXTERNAL.
Targeted efforts to reach, screen, and enroll people in the Extra Help program
To view this email as a web page, go
here.
|
|
|
Biden-Harris Administration Announces New Tools to Lower Prescription Drug Costs
The Biden-Harris Administration announced the June 12, 2023, release of a
new fact sheet about new tools that can lower prescription drug costs for low-income older adults and people with disabilities.
Included in the fact sheet is an announcement of ACL’s targeted efforts to reach, screen, and enroll people in the
Extra Help program. ACL’s efforts will specifically focus on Americans living in rural and underserved communities. These efforts will leverage data made available by CMS and involve ongoing technical assistance to grantees
in the Medicare Improvement for Patients and Providers Act (MIPPA) program, the State Health Insurance Assistance Program (SHIP), and other ACL grantees working with communities.
|
|
|
|
|
|
|
|
|
ACL.gov
Advancing independence, integration, and inclusion throughout life
|
|
|
|
|
|
|
|
|
This email was sent by: U.S. Department of Health and Human Services
200 Independence Avenue, S.W., Washington, DC, 20201 US
Privacy Policy
|
|
|
The information contained in this electronic mail and its attachments is privileged and confidential. It is intended for the use of the addressee and others specifically authorized to receive it. If you are not the intended recipient, you are prohibited from
disseminating, distributing or copying this communication. If you have received this e-mail in error, please delete it and notify us by replying to this e-mail immediately.
The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.
This email has been scanned for viruses and malware, and may have been automatically archived by Mimecast Ltd, an innovator in Software as a Service (SaaS) for business. Providing a safer and more useful place for your human generated data. Specializing in; Security, archiving and compliance. To find out more Click Here.
